Media-OutReach Newswire OneConnect Releases Q3 2024 Results with Net Profit attributable to Parent Company Reaching RMB110 million
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine